Moody Aldrich Partners’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-72,304	Closed	-$1.62M	–	162
2022 Q3	$1.62M	Buy	+72,304	New	+$1.62M	0.33%	91
2018 Q4	–	Sell	-98,993	Closed	-$1.61M	–	100
2018 Q3	$1.61M	Buy	98,993 +15,614	+19%	+$254K	0.46%	83
2018 Q2	$946K	Buy	+83,379	New	+$946K	0.34%	86